Page 29 - U.S. Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 10, 2026

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

711 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
REVB
US$1.17-6.4%-96.9%US$4.6mUS$19.250.561.4%n/a
OSRH
US$0.54-2.7%-62.8%US$16.9mUS$10.006.140.0%n/a
BGMS
US$1.010.4%-98.2%US$5.6mn/a7.5n/an/a
ICCC
US$7.089.9%30.8%US$65.0mn/a2.3n/an/a
CMND
US$1.2818.5%-96.6%US$2.5mn/a0.3n/an/a
OGEN
US$0.607.2%-89.5%US$2.7mn/a0.3n/an/a
PLRZ
US$10.83-10.3%-98.1%US$17.4mn/a0.8n/an/a
ANGN
US$1.0017.7%-37.9%US$30.1mn/a46.1-122.1%n/a
JUNS
US$0.408.2%-25.0%US$13.9mn/a663.8n/an/a
XCUR
US$3.78-9.9%-67.4%US$26.1mn/a6.1n/an/a
NTRB
US$3.907.4%-17.4%US$46.8mUS$15.0020.8n/an/a
BBLG
US$1.261.6%-71.6%US$2.3mUS$22.200.4n/an/a
ERNA
US$0.20-2.7%-93.2%US$6.0mn/a2.4n/an/a
AQB
US$0.936.7%46.0%US$4.8mn/a-2.2n/an/a
PMCB
US$0.65-5.3%-46.9%US$7.2mn/a0.2n/an/a
CDIO
US$1.83-10.3%-84.9%US$5.4mn/a365.3n/an/a
SXTC
US$2.3222.8%-99.4%US$1.9mn/a1.4n/an/a
NCEL
US$2.4910.4%n/aUS$9.5mn/a-0.6n/an/a
BRNS
US$0.57-5.4%-19.3%US$22.5mUS$5.500.3n/an/a
CVM
US$4.0717.3%-55.7%US$34.6mUS$25.003.0n/an/a
NNNN
US$27.104.8%330.8%US$1.2bn/a185.8n/an/a
FLNA
US$1.64-5.2%29.1%US$83.1mUS$8.001.1n/an/a
PPCB
US$0.10-12.0%-95.9%US$2.1mn/a0.2n/an/a
LITS
US$1.163.6%-38.0%US$42.5mn/a0.5n/an/a
Page 29 of 30